The goal of PEER-Heart is to implement and assess feasibility and preliminary effectiveness of a community peer-facilitated screening for methamphetamine-associated heart failure (MAHF) and linkage to evidence-based cardiology care for people who use methamphetamine in rural areas.
Patient-defined regular use of methamphetamine in the last year
Any methamphetamine use in the past 30 days
Age 18 years or older
No client-reported diagnosis of heart failure
Self-reported engagement in medical care for heart failure in past 6 months.
Actively taking medications for heart failure.
Parallel
Treatment as Usual
Other interventionPeer-facilitated referral to a local primary care provider to follow-up their screening results.
Telehealth-Cardiology
Other interventionPeer-facilitated virtual consultation with cardiovascular specialist, for follow-up of their screening results. Activities may include: referral for a locally performed testing including echocardiogram and additional blood work, and transitional care management facilitated by a remote nurse care manager and the peer Referral for a locally performed testing including echocardiogram Transitional care management facilitated by a remote nurse care manager and the peer
Linkage to cardiology care
Proportion of participants who are engaged in cardiac care at 2 months after screening.
Linkage to diagnostic echocardiogram
Proportion of participants who complete a diagnostic echocardiogram within 2 months after randomization.
Goal Directed Medical Therapy (GDMT) prescribed
Proportion of eligible patients who are on any GDMT at 6 months after randomization
Click on the lead sponsor to view all of their trials.
Oregon Health and Science University
Lead sponsor
University of Washington
Collaborator
Bay Area First Step
Collaborator
